Chemring Group PLC Director/PDMR Shareholding

RNS Number : 5902Q

Chemring Group PLC

18 December 2024

 

18 December 2024

 

Chemring Group PLC

 

Grant of deferred share award

 

 

Chemring Group PLC ("Chemring" or the "Company") announces that on 17 December 2024 it granted an award of 84,262 deferred 1p ordinary shares in the capital of the Company to Michael Ord, a director of the Company, in satisfaction of 40% of Mr Ord's annual bonus payment for the year ended 31 October 2024. The deferred share award will vest in three years' time. 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Michael Ord
2	Reason for the notification
a)	Position/status	Director/PDMR
b)	Initial notification /Amendment	Initial
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Chemring Group PLC
b)	LEI	213800U9A54VQJ5P2J41
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument   Identification code	Deferred award over 1p ordinary shares       GB00B45C9X44
b)	Nature of the transaction	Deferred award of shares in partial satisfaction of an annual bonus payment
c)	Price(s) and volume(s)	Price(s)   Volume(s)   Nil   84,262
d)	Aggregated information     - Aggregated volume     - Price	N/A
e)	Date of the transaction	17 December 2024
f)	Place of the transaction	Outside a trading venue

 

 

For further information:

 

Chemring Group PLC
Sarah Ellard	Group Legal Director & Company Secretary	[phone]

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHFLFLIFTLTLIS